What one share of DSwiss holds
One of the leading one-stop ODM/OEM manufacturing companies, DSwiss is a premier biotech nutraceutical firm that offers premium healthcare, skincare, and personal care products. At DSwiss, we procure excellent and precise formulation using the finest natural ingredients, developing effective solutions with alluring favours in a variety of forms.
DSwiss’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.00 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.00 |
| Cash and investments | $0.00 |
| Book value | $0.00 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2025 | $0.01 | −$0.00 | $0.00 | −$0.00 | — | $0.00 |
Common questions about DSwiss
How much does one share of DSwiss earn?
Over the last 12 months, DSwiss lost $0.00 for each share on $0.01 of sales.
Does DSwiss pay a dividend?
DSwiss didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is DSwiss’s book value per share?
DSwiss’s book value is $0.00 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of DSwiss have?
Each share of DSwiss has $0.00 of cash and investments, as of June 30, 2026.
What is DSwiss’s free cash flow per share?
−$0.00 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.